Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2.
about
Serum amyloid A: an acute-phase protein involved in tumour pathogenesisGenome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A.Familial amyloidosis in cats: Siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition.Serum amyloid A: from fibril to function. Current status.Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis.Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channelCharacterization of the oligomerization and aggregation of human Serum Amyloid AOrganization and biology of the porcine serum amyloid A (SAA) gene cluster: isoform specific responses to bacterial infectionSerum amyloid A and inflammation in diabetic kidney disease and podocytes.Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritisMass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.The genetics of the amyloidoses: interactions with immunity and inflammation.Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts.The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A.Amyloid persistence in decellularized liver: biochemical and histopathological characterization.Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm FormationMass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.Serum amyloid A1: Structure, function and gene polymorphism.Up-regulation of MUC2 mucin expression by serum amyloid A3 protein in mouse colonic epithelial cells.Serum amyloid A as a marker and mediator of acute coronary syndromes.Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice.Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.Influence of C-terminal truncation of murine Serum amyloid A on fibril structure.Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1.Functional analysis of a minimal mouse serum amyloid A3 promoter in transgenic mice.Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response.Spontaneous pneumoperitoneum: an unusual complication of systemic reactive AA amyloidosis secondary to rheumatoid arthritis.Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.Development of quantitative mass spectrometric immunoassay for serum amyloid A.Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.Pulmonary and systemic induction of SAA3 after ventilation and endotoxin in preterm lambs.Analysis of cDNA sequences of feline SAAs.An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians.Serum amyloid A: an ozone-induced circulating factor with potentially important functions in the lung-brain axis.Carbamylation of the amino-terminal residue (Gly1) of mouse serum amyloid A promotes amyloid formation in a cell culture model.Serum amyloid a protein in clinical cancer diagnosis.Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains.Slower clearance of human SAA1.5 in mice: implications for allele specific variation of SAA concentration in human.
P2860
Q28291806-6A64C1A6-04CF-4C93-B006-3DACBF0D0DD3Q33761277-C997A1DF-FFFD-4672-889F-56B4B51872DDQ33877318-8206EDDF-60A6-4009-88BB-52B5E19B19EFQ33937054-B3D48687-2DFF-431F-B3CD-8D71FBC15264Q34147275-A13E2107-98CA-4CFB-A85C-4CA6878C30A4Q34414931-4C2D2F5B-2A38-47CE-9EF2-78D50CC5445FQ34764150-8E253800-3D2C-4839-90F5-2B3306BD5F15Q35022915-ED478B1E-8350-4B25-8C41-4D578E70D9A1Q35138098-A9F3E03A-F55E-460A-82F2-460AE340DD39Q35410684-8E681C9C-3CA8-479C-948F-2E6E5730E056Q35550047-FF05EEF5-EA45-488A-B6C5-2592B0AD837CQ36072250-A007DA52-44A8-4680-9739-DC0067293623Q36534748-C89A833A-9DE4-43B2-9925-A379DF36BA67Q36594661-70E8040B-2E78-4913-BA84-ACF8DE0810FAQ36610558-9DBF2B43-355F-42F5-9677-C24060AB1D0AQ36761783-D0F778E3-59B6-47AF-A1BE-6CCB8A641AA3Q36771716-42F4991E-7FD6-48AE-ACE9-1C150E1CCEB7Q37566426-ABB0F849-FDC6-432F-A759-9740CF4FC166Q38761950-1BCE4713-C8FF-43B8-9371-5BFC4878EEF3Q39008807-D464FC60-0754-4122-B042-AB8AE90BC98DQ39941673-DD97935F-833D-43C8-9337-FDC03EE96B3BQ40558606-25EE1782-E7DF-49CE-8B68-90D375A9F348Q40694535-41D81CBD-18EB-4FAA-A0B9-AA55BBABAA94Q40987901-E4D83727-2B6E-473F-AC40-60F555C8538BQ41094376-BEE67016-5DB8-430B-8753-D03CEDC5A958Q41915318-32576D6A-3C84-4162-BE38-0A9DC7965DE5Q42515718-9EAC6460-4EE8-4FFC-9042-B3DC13068839Q44300028-8E7DD8CD-4295-4E09-A704-3F4454C65ADBQ44450464-FE5A87DD-E131-41E5-BAE0-8B5F6675FB6DQ44930018-8E3C95D4-6F9A-4D11-AAF1-715D00F44803Q46155938-6C056D67-B0E8-43AD-9945-AD2E092DDCA5Q46502103-DD4D1C01-0212-4E4E-827D-8F67CB66E6A2Q46818491-449FEA76-80ED-40B7-8111-0F1FA4416409Q47374790-017DF293-81F1-460E-9705-6008DB430570Q47613463-46939C65-3D27-419B-BAE5-3597F23BD1E9Q47756327-188A6FAC-BFBA-4CB7-A1EB-54EB295CF579Q51351788-EEF031D6-5958-4B78-839F-1F87C3A55556Q53282038-980BF850-5511-4769-96E6-E426FE10CA00Q54049160-2E8922B4-108E-41CF-AE16-1F7A3EA1065FQ54514876-B8412BB7-F0FB-402D-A476-D6A4802E97BD
P2860
Revised nomenclature for serum amyloid A (SAA). Nomenclature Committee of the International Society of Amyloidosis. Part 2.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Revised nomenclature for serum ...... ociety of Amyloidosis. Part 2.
@en
Revised nomenclature for serum amyloid A
@nl
type
label
Revised nomenclature for serum ...... ociety of Amyloidosis. Part 2.
@en
Revised nomenclature for serum amyloid A
@nl
prefLabel
Revised nomenclature for serum ...... ociety of Amyloidosis. Part 2.
@en
Revised nomenclature for serum amyloid A
@nl
P2860
P1433
P1476
Revised nomenclature for serum ...... ociety of Amyloidosis. Part 2.
@en
P2093
P2860
P356
10.3109/13506129908993291
P577
1999-03-01T00:00:00Z